Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines (sched1)

NCT00197808 Phase 4 COMPLETED

The purpose of the study is to evaluate the immune responses of UK infants after one or two doses of pneumococcal conjugate vaccine or one or two doses of three different types of meningococcal conjugate vaccine given at either two and three or two and four months of age.

Details

Lead sponsor	Public Health England
Phase	Phase 4
Status	COMPLETED
Enrolment	392
Start date	2005-04
Completion	2010-01

Conditions

• Pneumococcal Infections
• Meningococcal Infections

Interventions

• menjugate
• Men C conjugate vaccine
• Men C conjugate
• Men C Conjugate
• Men C conjugate
• Men C conjugate

Primary outcomes

• Immunogenicity — 3 months after last sample
  SBA men C responses

Countries

United Kingdom